Verrica Pharmaceuticals Inc. Common Stock Share Price
NASDAQ: VRCAHealthcare
Live Verrica Pharmaceuticals Inc. Common Stock Share Price Chart
O H L
Verrica Pharmaceuticals Inc. Common Stock Performance Overview
Days Range
▼
$4.07Low
$4.20High
Markets Today
| Previous Close | $4.14 |
|---|---|
| Open | $4.20 |
| Volume | 19,254 |
| Day's Range | $4.07 - $4.20 |
| 52W Range | $3.28 - $9.82 |
| Market Cap | $72.32 M |
Historical Performance
| 1M Returns | -21.29 |
|---|---|
| 3M Returns | -37.46 |
| 6M Returns | -28.87 |
| 1Y Returns | -6.33 |
| 5Y Returns | -96.66 |
| 10Y Returns | NA |
Verrica Pharmaceuticals Inc. Common Stock Fundamentals
| Market Cap | $72.32 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.58 M |
| ROE TTM | -2.40 |
| EPS TTM | $-1.67 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 16.79 |
| EBITDA | $-11.81 M |
| Profit Margin | -50.27 |
| Market Cap | $72.32 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.58 M |
| ROE TTM | -2.40 |
| EPS TTM | $-1.67 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 16.79 |
| EBITDA | $-11.81 M |
| Profit Margin | -50.27 |
Verrica Pharmaceuticals Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $3.44 M | $12.70 M | $14.34 M | $5.09 M | $5.02 M | $5.86 M |
| Gross Profit + | $3.00 M | $12.21 M | $13.23 M | $3.69 M | $4.13 M | $4.98 M |
| Operating Income | -$8.13 M | $1.51 M | $1.63 M | -$6.95 M | -$9.71 M | -$13.10 M |
| EBITDA | -$8.08 M | $1.55 M | $1.65 M | -$6.93 M | -$9.70 M | -$11.38 M |
| Interest Expense | -$2.20 M | -$2.13 M | -$2.09 M | -$1.31 M | -$160.00 K | -$164.00 K |
| Depreciation | $52.00 K | $44.00 K | $23.00 K | $14.00 K | $17.00 K | $1.71 M |
| Income Before Tax | -$9.74 M | $204.00 K | -$274.00 K | -$8.07 M | -$9.68 M | -$13.15 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$9.74 M | $204.00 K | -$274.00 K | -$8.07 M | -$9.68 M | -$13.15 M |
| Net Profit Margin | -283.28% | 1.61% | -1.91% | -158.56% | -192.75% | -224.38% |
Verrica Pharmaceuticals Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $1.00 K | $1.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$316.77 M | -$316.56 M | -$316.84 M | -$324.91 M | -$334.60 M | -$347.75 M |
| Non-Current Liabilities | $31.36 M | $27.37 M | $29.03 M | $5.95 M | $6.51 M | $9.27 M |
| Current Liabilities | $29.40 M | $29.22 M | $33.60 M | $21.50 M | $22.03 M | $30.86 M |
| Total Liabilities | $60.75 M | $56.59 M | $57.94 M | $22.39 M | $22.73 M | $31.71 M |
| Fixed Assets | $537.00 K | $315.00 K | $225.00 K | $209.00 K | $191.00 K | $177.00 K |
| Current Assets | $39.47 M | $36.78 M | $36.27 M | $42.54 M | $34.13 M | $32.64 M |
| Total Assets | $42.18 M | $39.11 M | $40.90 M | $47.13 M | $38.79 M | $36.02 M |
Verrica Pharmaceuticals Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$9.74 M | $204.00 K | -$274.00 K | -$8.07 M | -$9.68 M | -$13.15 M |
| Operating Cash Flow | -$12.68 M | -$10.04 M | $9.69 M | -$4.59 M | -$9.16 M | -$9.28 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$4.06 M | -$4.16 M | -$3.98 M | $13.64 M | -$120.00 K | -$126.00 K |
| Change in Cash | -$16.73 M | -$14.20 M | $5.70 M | $9.05 M | -$9.28 M | -$9.40 M |
Verrica Pharmaceuticals Inc. Common Stock Return Calculator
The Verrica Pharmaceuticals Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$330
Invested Amount$10,000
Est. Returns$-9,670
About Verrica Pharmaceuticals Inc. Common Stock
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.
Popular Stocks
FAQs
What is the share price of Verrica Pharmaceuticals Inc. Common Stock today?
Verrica Pharmaceuticals Inc. Common Stock (VRCA) share price as of October 8, 2026 is $4.10. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Verrica Pharmaceuticals Inc. Common Stock?
Yes, Indian Investors can invest in the Verrica Pharmaceuticals Inc. Common Stock (VRCA) Share by opening an international trading account with Angel One.
How can I purchase Verrica Pharmaceuticals Inc. Common Stock shares in India?
Purchasing Verrica Pharmaceuticals Inc. Common Stock (VRCA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Verrica Pharmaceuticals Inc. Common Stock (VRCA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Verrica Pharmaceuticals Inc. Common Stock?
Yes, you can purchase fractional shares of Verrica Pharmaceuticals Inc. Common Stock (VRCA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Verrica Pharmaceuticals Inc. Common Stock?
The market capitalization of Verrica Pharmaceuticals Inc. Common Stock on October 8, 2026, is $72.32 M.
In which sector Verrica Pharmaceuticals Inc. Common Stock belongs?
Verrica Pharmaceuticals Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Verrica Pharmaceuticals Inc. Common Stock stocks?
In order to invest in Verrica Pharmaceuticals Inc. Common Stock (VRCA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
